Chemistry? Clays? Isn’t this a biologics company?
I’m a chemist working on clay for a biologics company. That may well sound like a juxtaposition. Add to that the fact that the biological application isn’t to do with creatures in the [...]
Renovos wins Innovate UK SMART grant
We are excited to announce that we have launched another project funded by Innovate UK! Renovos won funding via the highly competitive SMART competition run by Innovate UK, the UK’s innovation [...]
Renovos Biologics has appointed Patrick O’Donnell as Advisor to the Board
Patrick O’Donnell Previously a General Manager and Executive Vice-President of North America for BoneSupport A.B., CEO at Proteothera, Inc, Histogenics Corporation, Prochon-BioTech, and in [...]
Three new nanoclay publications out this year!
Key read for nanoclays in drug delivery – group’s new publication on nanoclay in Nature Communications! The paper, which can be found here, reports on the use of bisphosphonate [...]
Renovos and its Nanoclay technology reviewed by Orthoworld
Renovos and our advanced nanoclay biomaterial, Renovite®, has been featured in Orthoworld. The article, “Renovos to Develop Next-Gen Technology to “Tame” BMP-2 Diffusion”, outlines key issues [...]
Renovos receives investment for nanoclay innovation from leading medical research charity Orthopaedic Research UK
Renovos has recently been awarded one of the very first charity investments in the UK. In a progressive move to find new ways to support people living with painful and debilitating bone and joint [...]
Our nanoclay has been featured on the cover of Orthoworld’s Bonezone!
The synthetic nanoclay gel scaffold effectively localises new bone formation (in red). It offers injectable delivery and retention of biologics, released only to in-growing cells for efficacy at [...]
INNOVATION CHALLENGE FINALIST AT RESI IN BOSTON
The Redefining Early Stage Investments (RESI) Conference took place on Wednesday 11th September 2019 in Boston. The organisers at Life Science Nation (LSN) invite all global early-stage [...]
RENOVOS AND CALTAG AT BRS/BORS CARDIFF
Working with Caltag Medsystems at BRS/BORS 2019 to spead the word about Renovos and our mesenchymal stem cell products. Together with Hannah from Caltag Medsystems, Renovos participated in Bone [...]
Renovos Biologics has appointed Simon Sinclair as non-executive director
Simon Sinclair Previously in clinical trials at Merck & Co. Inc. and in medical affairs at DePuy Synthes and Johnson & Johnson, Simon is now working in safety and vigilance at RB. This [...]